| Ytd | -83.13% | |
| 1y | -88.70% |
| Open | 2.47 | Prev Close | 2.54 | Low | 1.73 | High | 2.47 | Mkt Cap | 2.73M |
| Vol | 128.30K | Avg Vol | 65.51K | EPS | 7904.00 | P/E | 0.00 | Forward P/E | -2.14 |
| Beta | 1.10 | Short Ratio | 0.56 | Inst. Own | 18.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-30 | 50-d Avg | 11.01 | 200-d Avg | 140.48 | 1yr Est | 9.50 |
ENLV News
• 135 patients, out of a total planned 182, have been randomized and were administered the firs
• 135 patients, out of a total planned 182, have been randomized and were administered the firs
Nes-Ziona, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "
RingCentral surged 15% after beating Q3 estimates and raising FY26 guidance; XXII, LABT and HUBC led
Enlivex Ltd. (NASDAQ:ENLV) ("Enlivex" or the "Company"), a quality longevity company
Nes-Ziona, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 17.9% to $0.16 during Monday's afte
Non-clinical R&D activities to be wound down; resources to be focused on executing the Phase 2b
Nes-Ziona, Israel, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the
Gainers SCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thu
S&P 500 to open higher? Polymarket odds reach 70% as Wall Street digests September jobs, 24-year
Enlivex Therapeutics Ltd. (NASDAQ: ENLV - Get Free Report) was the target of a significant drop in s
Gainers Jaguar Health (NASDAQ:JAGX) stock increased by 304.5% to $10.8 during Tuesday's regular
Nes-Ziona, Israel, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd.
Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 330.8% to $6.16 during Thursday's regular ses
Enlivex Ltd. (ENLV) appears to have found support after losing some value lately, as indicated by th
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 68.4% to $7.68 during Tuesday
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session
BioStem Technologies (OTCMKTS:BSEM - Get Free Report) and Enlivex Therapeutics (NASDAQ: ENLV - Get F
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and
Enlivex Ltd. (NASDAQ:ENLV, "Enlivex" or the "Company")), a quality longevity company
As of July 29, 2026, trading volume on the Rain protocol reached $860MM1 622% month-over-month grow
Webinar to cover the rationale and value creation potential of the recently announced private placem
Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular se
US stocks trade higher, Dow up 1% on Tuesday. Boeing gains 5% after reporting Q2 results. Kiniksa Ph
Dow Jones up 350 points, NASDAQ down. Coca-Cola shares rise 6% after better-than-expected earnings.
Price of $5.00 per share for subscription amounts funded in U.S. dollars, USDT or USD Coin and $6.00
Nes-Ziona, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or “the C
Enlivex Therapeutics (NASDAQ: ENLV - Get Free Report) and Korro Bio (NASDAQ: KRRO - Get Free Report)
Nes-Ziona, Israel, July 20, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "C
Enlivex Ltd. (ENLV) might move higher on growing optimism about its earnings prospects, which is ref
The heavy selling pressure might have exhausted for Enlivex Ltd. (ENLV) as it is technically in over
Nes-Ziona, Israel, July 13, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "
Nes-Ziona, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "
Nes-Ziona, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “ Enlivex ” or the
Enlivex Ltd. (NASDAQ:ENLV, "Enlivex" or the "Company")), a quality longevity company
Nes-Ziona, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "C
The patent will provide Enlivex with added intellectual property protection in Australia through at
Nes-Ziona, Israel, June 15, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "
The data were selected for an oral podium presentation at EULAR and will be presented by Prof. Phili
The global, multicenter, randomized, double-blind, placebo-controlled Phase 2b clinical trial is des
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and
The U.S. Food and Drug Administration (FDA) has cleared Enlivex's Investigational New Drug (IND)
Enlivex's RAIN token begins trading on KuCoin as analysts raise price targets, citing growing pr
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex Therapeutics (NASDAQ:ENLV) w
– Enlivex has adopted the world's first RAIN prediction markets token digital asset treasury str